Webinar Sponsored by
Webinar Sponsored by
ObvioHealth, a pioneering VRO (Virtual Research Organization) will share case studies and insider insights based on more than 30 fully virtual or hybrid studies conducted across 20 countries and 13 therapeutic areas. This webinar will answer questions like: How do you determine whether a trial can go virtual? What data collection methods are best adapted to a decentralized trial? Can virtual assistants really improve compliance? A step-by-step virtual trial playbook for sponsors wishing to embark on a DCT journey.
10:00 AM (IST) | 12:30 PM (SGT) | 3:30 PM (AEDT)
Erin has 20+ years experience in the management, direction and oversight of global clinical operations leadership teams, working across pharmaceutical and CRO operating environments. She honed her skills and interest in clinical project management at Merck Asia Pacific and went on to hold positions at several CRO’s including George Clinical and Syneos, Erin’s expertise extends to corporate strategy development and execution, business development, sales and marketing and global clinical trial management. She is passionate about team leadership, development and empowerment and has brought those passions to the planning and execution of virtual clinical trials in Asia.
Matty has more than 27 years of industry experience in pharmaceutical research primarily in the area of Clinical Operations. She has managed advanced research programs maintaining a deep comprehension of the drug and device development processes, specializing in phases I-IV studies, device, post-approval research, observational studies and recently specializing in decentralized clinical trials. Matty has spent that majority of her career developing robust research programs from the ground up for multi-therapeutic practices and hospitals across the country. Academically, Matty received Bachelor of Science in Nursing degree from The Florida State University.
With 25+ years’ experience as a leader in clinical trials/healthcare and eclinical technology for biopharmaceutical and health-related consumer goods companies, Susan has deep knowledge in developing/implementing novel approaches which improve the quality and efficacy of clinical trials. She is skilled in leveraging patient-centricity to boost engagement and compliance for better data capture, quality and completeness. Susan’s areas of expertise include rater, patient and caregiver training, electronic PRO (ePRO), and electronic ClinRO and instrument development and validation. Susan began her career at Harvard Medical School, first as Principal Investigator and Lab Director at the Children’s Hospital, then as Research Director for Dana Farber. She then went on to roles as a Senior Scientist for Biogen, VP of Clinical Science at ERT and Senior Principal Clinical Consultant at Oracle Health Sciences before coming to ObvioHealth. Dallabrida holds a doctorate from Pennsylvania State University College of Medicine with a Ph.D. in Biochemistry and Molecular Biology and has more than 35 publications 4 patents, 25 white papers and 18 awards to her name.